Track topics on Twitter Track topics that are important to you
Novartis, Amgen halt clinical testing of BACE inhibitor umibecestat in Alzheimer's disease prevention after patients worsened http://www.firstwordpharma.com/node/1652605?tsid=28®ion_id=6#axzz5tOBYUG7c …
Original Article: Novartis, Amgen halt clinical testing of BACE inhibitor umibecestat in Alzheimer's disease prevention after patients worsened http://www.firstwordpharma.com/node/1652605?tsid=28®ion_id=6#axzz5tOBYUG7c …NEXT ARTICLE
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...